Sort
82,697 grants matching “vaccine development”
Multicenter AIDS Cohort Study
$3,778,012Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,775,841Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
HIV VACCINE DESIGN &DEVELOPMENT TEAMS
$3,773,578Wyeth-Lederle Vaccines · N01 · FY2000 · AI
Harnessing CD4+ T cell responses for long-term protective immunity against HIV
$3,773,378Rafi Ahmed · Scripps Research Institute, The · UM1 · FY2014 · AI
Agents of Bioterrorism: Pathogenesis and Host Defense
$3,772,711Jorge L. Benach · State University New York Stony Brook · P01 · FY2010 · AI
Core Support for Cancer Research Center
$3,768,040Yeshiva University · P30 · FY2002 · CA
Drug Repurposing Screening for Rare and Neglected Diseases
$3,765,980Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Animal Medicine Infrastructure Support
$3,765,957Ruth Woodward · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
$3,764,013Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR
The UCSD CD4 Collaborative Clinical Trial Unit
$3,763,076Constance Ann Benson · University Of California, San Diego · UM1 · FY2020 · AI
In vivo virology core
$3,760,731Adolfo Garcia-Sastre · University Of California, San Francisco · U19 · FY2022 · AI
Scientific Research Support Component C/Non- Human Primates
$3,756,131Dan H. Barouch · Scripps Research Institute, The · UM1 · FY2012 · AI
RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 Testing
$3,755,728Mario Castro · University Of Kansas Medical Center · UL1 · FY2020 · TR
Core Support for Cancer Research Center
$3,755,651Yeshiva University · P30 · FY2003 · CA
Integrated Approach to Host-Pathogen Interactions
$3,755,247Mary Galinski · Emory University · N01 · FY2014 · AI
Center for Human Immunology
$3,754,469John Tsang · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Project 1: Computational methods
$3,753,275David Baker · University Of Washington · U19 · FY2024 · AI
Novel TLR7/8 agonists as adjuvants for rapid-acting vaccines
$3,750,387David Johnson · Corixa Corporation · N01 · FY2013 · AI
ORALE COVID-19!: Organizaciones para Reducir, Avanzar y Lograr Equidad contra el COVID-19 (Organizations to Reduce, and to Advance, and Lead for Equity against COVID-19)
$3,750,373Irva Hertz-Picciotto · University Of California At Davis · P30 · FY2020 · ES
Clinical and Translational Science Award
$3,750,000Reza Shaker · Medical College Of Wisconsin · UL1 · FY2020 · TR
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORK
$3,749,873University Of Alabama At Birmingham · U01 · FY2004 · HD
Preclinical Development and Clinical Proof of Concept of a Synthetic Nanoparticle
$3,748,514Lloyd Patrick Johnston · Selecta Biosciences, Inc. · U01 · FY2015 · DA
Combined Approach to Broadly Protective AIDS Vaccines
$3,748,460University Of Washington · P01 · FY2005 · AI
Tulane University COVID Antibody and Immunity Network (TUCAIN)
$3,743,182James E Robinson · Tulane University Of Louisiana · U54 · FY2020 · CA
IP24-045, PREVENT: Preparedness through Respiratory Virus Epidemiology and Community Engagement
$3,739,804Louise Chang Laurent · University Of California, San Diego · U01 · FY2025 · IP